Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04841317 · ClinicalTrials.gov registry record · NA
Mobile Technology for Blood Pressure Management
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT04841317: Completed NA study, sponsored by Stanford University.
NCT04841317 is a NA study that has completed, run by Stanford University. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04841317, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the feasibility and effectiveness of a mobile-technology based system that integrates patient-facing and clinician-facing components to assist the management of hypertension.
Interventions
- COMBINATION_PRODUCT Mobile technology intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2021-03-31 |
| Est. Completion | 2021-12-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04841317
The ClinicalTrials.gov registry entry for NCT04841317 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mobile technology intervention is the first listed.
NCT04841317 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04841317 about?
NCT04841317 is a clinical study titled "Mobile Technology for Blood Pressure Management". The primary objective of this study is to assess the feasibility and effectiveness of a mobile-technology based system that integrates patient-facing and clinician-facing components to assist the management of hypertension.
What is the current status of trial NCT04841317?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2021-03-31. Estimated completion is 2021-12-07.
What interventions are being tested in trial NCT04841317?
The interventions under investigation include: Mobile technology intervention (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04841317?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.